Hemp & Cannabinoid Science
A research reference for the hemp industry: enzyme pharmacology, terpene and cannabinoid chemistry, extraction and purification, formulation and dosing safety, analytics, and the regulatory argument — sourced, cross-linked, and honest about what is not known.
11
shelves
81
pages
558
sections
623
citations
483
with a resolved identifier
167,256
words
What this section is, and what it is not
Education and harm reduction. Not medical, legal or financial advice. Every factual claim carries a source; contested and single-source claims are marked as such on the page.
The boundary. This section teaches separation, purification, formulation, dosing arithmetic and analytical chemistry with real parameters, because withholding that detail from someone who will proceed anyway is the harm this library exists to prevent. It does not publish preparative routes for converting one cannabinoid into a more intoxicating one; those are described structurally and cited to the literature, without procedures.
Tools
Interaction checkerName what you are taking. The engine reports documented interactions with the mechanism named — and states plainly what it did not check.
CYP interaction matrix (JSON)The machine-readable substrate/inhibitor/inducer table, generated from the CYP450 shelf so the data and the pages cannot disagree.
The shelves
Cannabinoid Science
The structural chemistry of the phytocannabinoid family: eleven classes, the C1-to-C8 side-chain series and its structure-activity relationship, ring arrangement and pharmacology, isomerism and the analytics it forces, plant biosynthesis, decarboxylation arithmetic, the transformation matrix, and the pharmacological line between a phytocannabinoid and a synthetic cannabimimetic.
10 pages · updated 2026-09-27
Terpene Monographs
Per-compound reference: structure, formula, boiling point, documented receptor activity, botanical sources by percent of volatile fraction, and vaporization bands.
12 pages · updated 2026-09-27
Endocannabinoid Modulation
The receptors, the two hydrolases, the contested transport step, and the botanical chemistry that acts on them — with the ceiling that separates enzyme inhibition from direct agonism.
10 pages · updated 2026-09-27
Botanical Monographs
Research-grade monographs on the botanicals that touch cannabinoid pharmacology, liver metabolism and the temple materia medica — chemotype data, mechanism-level pharmacology, and interactions with the mechanism named.
3 pages · updated 2026-09-27
Cytochrome P450 Hub
The enzymes and transporters that set cannabinoid and drug exposure: six CYP isoforms, phase-2 glucuronidation and sulfonation, P-glycoprotein efflux, and the mechanism rules that generalise where an interaction pairs list cannot.
11 pages · updated 2026-09-27
Extraction, Separation and Purification
The unit operations that turn plant material into a specified product: choosing an extraction platform, short-path and wiped-film distillation, solvent recovery, winterization, decarboxylation, crystallisation of isolate, preparative chromatography, and capturing the terpene fraction before heat destroys it.
9 pages · updated 2026-09-27
Product Formulation
From refined extract to finished product: terpene reintroduction and strain-profile reconstruction, vape viscosity and crystallisation with cannabitriol treated as a working material, carriers and diluents ranked by route with the EVALI case told properly, edible dose uniformity, and deliberate CBN production as controlled oxidative aging.
5 pages · updated 2026-09-27
Formulation and Dosing Safety
Hot spots, dose arithmetic, homogeneity, residual solvent, titration and adulterants: the handling steps between an obtained compound and a dose, and the documented ways each one has killed people.
6 pages · updated 2026-09-27
Product Safety and Analytical Integrity
What the K2 era actually failed at — the scheduling regime that selected for the more dangerous compounds, documented turn by turn in the Federal Register, and the distribution layer that could not handle what it was given — what the published surveys find in converted cannabinoid products, how to recognise synthetic-cannabinoid toxicity against cannabis overconsumption, and the buyer and vendor instrument that separates a tested market from the failure mode.
4 pages · updated 2026-09-27
Reading a Certificate of Analysis
What a COA is and is not, the total-THC decarboxylation arithmetic done properly, what each analytical panel does and does not cover, and a red-flag checklist.
4 pages · updated 2026-09-27
Regulatory and Legal Analysis
ANALYSIS AND ADVOCACY, NOT LEGAL ADVICE — cannabinoid scheduling varies by state, is changing fast, and a compound lawful federally may be a felony locally; do not act on these pages without your own counsel. Seven pages: the statutory landscape after the 2018 Farm Bill, the Federal Analogue Act and the "substantially similar" doctrine, the prong-by-prong case that the side-chain homologs are not analogues, the 2025 appropriations redefinition and its 0.4 mg per-container threshold, the market and product-safety consequences, the analogue treadmill and the Federal Register record showing that compound-by-compound prohibition selects for more dangerous compounds, and a state research-positioning argument.
7 pages · updated 2026-09-27
Absence is not safety. A substance or a pair that is not in this section was not checked and is not thereby safe. This is a curated mechanism reference built from primary literature and regulatory reference works — not a comprehensive interaction database, and not a substitute for a clinician or a pharmacist.
The rest of the library
Interaction checker (full dataset)
The whole mechanism engine — MAOIs, serotonergic drugs, the CYP axis, P-gp, tyramine, and now the endocannabinoid enzymes and CB1/CB2 from this section.
Oilahuasca & allylbenzene metabolism
The CYP-mediated allylbenzene shelf: the same phase-1 enzymes read from the other direction, with the MAOI and 2C-series pharmacology attached.
Herbs & the temple pharmacopoeia
The botanical shelves this section's monographs were drawn from — kava potentiators, the Van Kush pharmacopoeia, ethnobotany.
Psychedelics & harm reduction
Dose ranges, testing, set and setting, aftercare and emergency guidance, with the same sourcing discipline.